Xiao-yan Feng
Tianjin Key Laboratory On Technologies Enabling Development Of Clinical Therapeutics And Diagnostics
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In-silico identification of peroxisome proliferator-activated receptor (PPAR)α/γ agonists from Ligand Expo Components database.
Journal: Journal of biomolecular structure & dynamics
Published: March 20, 2020
Virtual identification of novel peroxisome proliferator-activated receptor (PPAR) α/δ dual antagonist by 3D-QSAR, molecule docking, and molecule dynamics simulation.
Journal: Journal of biomolecular structure & dynamics
Published: September 27, 2019
Virtual identification of novel PPARα/γ dual agonists by 3D-QSAR, molecule docking and molecular dynamics studies.
Journal: Journal of biomolecular structure & dynamics
Published: August 17, 2019
Discovery of novel and highly selective PI3Kδ inhibitors based on the p110δ crystal structure.
Journal: Journal of biomolecular structure & dynamics
Published: June 25, 2019
Identification of novel PPARα/γ dual agonists by pharmacophore screening, docking analysis, ADMET prediction and molecular dynamics simulations.
Journal: Computational biology and chemistry
Published: September 03, 2018
Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Journal: Computational biology and chemistry
Published: July 19, 2018
Fragmented QRS (fQRS) Complex Predicts Adverse Cardiac Events of ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and Thrombolysis.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 06, 2018
Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.
Journal: Journal of biomolecular structure & dynamics
Published: October 31, 2017
Clinical feature and efficacy of patients with multiple myeloma and renal impairment treated with bortezomib based chemotherapy
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 15, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026